77 related articles for article (PubMed ID: 20455727)
1. HMG-CoA reductase inhibitor lovastatin causes reversible cytoskeleton perturbation by RhoA signalling suppression in peritoneal cell line Met5A.
Suzuki N; Imai A
J Obstet Gynaecol; 2010 May; 30(4):404-7. PubMed ID: 20455727
[TBL] [Abstract][Full Text] [Related]
2. Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling.
Zhong WB; Liang YC; Wang CY; Chang TC; Lee WS
Endocr Relat Cancer; 2005 Sep; 12(3):615-29. PubMed ID: 16172195
[TBL] [Abstract][Full Text] [Related]
3. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI
Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors.
Kusama T; Mukai M; Iwasaki T; Tatsuta M; Matsumoto Y; Akedo H; Nakamura H
Cancer Res; 2001 Jun; 61(12):4885-91. PubMed ID: 11406567
[TBL] [Abstract][Full Text] [Related]
5. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity.
Aarons CB; Cohen PA; Gower A; Reed KL; Leeman SE; Stucchi AF; Becker JM
Ann Surg; 2007 Feb; 245(2):176-84. PubMed ID: 17245169
[TBL] [Abstract][Full Text] [Related]
6. HMG-CoA reductase inhibitors reduce nicotine-induced expression of cellular adhesion molecules in cultured human coronary endothelial cells.
Cirillo P; Pacileo M; De Rosa S; Calabrò P; Gargiulo A; Angri V; Prevete N; Fiorentino I; Ucci G; Sasso L; Petrillo G; Musto D'Amore S; Chiariello M
J Vasc Res; 2007; 44(6):460-70. PubMed ID: 17657162
[TBL] [Abstract][Full Text] [Related]
7. Lovastatin-induced cytoskeletal reorganization in lens epithelial cells: role of Rho GTPases.
Maddala RL; Reddy VN; Rao PV
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2610-5. PubMed ID: 11581207
[TBL] [Abstract][Full Text] [Related]
8. Lovastatin-induced PC-12 cell differentiation is associated with RhoA/RhoA kinase pathway inactivation.
Fernández-Hernando C; Suárez Y; Lasunción MA
Mol Cell Neurosci; 2005 Aug; 29(4):591-602. PubMed ID: 15951198
[TBL] [Abstract][Full Text] [Related]
9. Role of Rho protein in lovastatin-induced breakdown of actin cytoskeleton.
Koch G; Benz C; Schmidt G; Olenik C; Aktories K
J Pharmacol Exp Ther; 1997 Nov; 283(2):901-9. PubMed ID: 9353412
[TBL] [Abstract][Full Text] [Related]
10. Effects of cholesterol-lowering statins on the aqueous humor outflow pathway.
Song J; Deng PF; Stinnett SS; Epstein DL; Rao PV
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2424-32. PubMed ID: 15980231
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
12. MCP-1-induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-, but not ERK1/2-dependent pathway.
Hiraoka M; Nitta N; Nagai M; Shimokado K; Yoshida M
Life Sci; 2004 Jul; 75(11):1333-41. PubMed ID: 15234191
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells.
Li X; Liu L; Tupper JC; Bannerman DD; Winn RK; Sebti SM; Hamilton AD; Harlan JM
J Biol Chem; 2002 May; 277(18):15309-16. PubMed ID: 11839765
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of RhoA enhances peritoneal dissemination: RhoA suppression with Lovastatin may be useful for ovarian cancer.
Horiuchi A; Kikuchi N; Osada R; Wang C; Hayashi A; Nikaido T; Konishi I
Cancer Sci; 2008 Dec; 99(12):2532-9. PubMed ID: 19038009
[TBL] [Abstract][Full Text] [Related]
15. Effects of HMG-CoA reductase inhibition on PDGF- and angiotensin II- mediated signal transduction: suppression of c-Jun and c-Fos in human smooth muscle cells in vitro.
Kreuzer J; Watson L; Herdegen T; Loebe M; Wende P; Kübler K
Eur J Med Res; 1999 Apr; 4(4):135-43. PubMed ID: 10205288
[TBL] [Abstract][Full Text] [Related]
16. The role of geranylgeranylated proteins in human mesangial cell proliferation.
Khwaja A; Sharpe CC; Noor M; Hendry BM
Kidney Int; 2006 Oct; 70(7):1296-304. PubMed ID: 16929252
[TBL] [Abstract][Full Text] [Related]
17. Increased RhoA and RhoB protein accumulation in cultured human trabecular meshwork cells by lovastatin.
Von Zee CL; Richards MP; Bu P; Perlman JI; Stubbs EB
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2816-23. PubMed ID: 19151402
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA.
Tang D; Park HJ; Georgescu SP; Sebti SM; Hamilton AD; Galper JB
Life Sci; 2006 Sep; 79(15):1484-92. PubMed ID: 16740276
[TBL] [Abstract][Full Text] [Related]
19. RhoA-mediated, tumor necrosis factor alpha-induced activation of NF-kappaB in rheumatoid synoviocytes: inhibitory effect of simvastatin.
Xu H; Liu P; Liang L; Danesh FR; Yang X; Ye Y; Zhan Z; Yu X; Peng H; Sun L
Arthritis Rheum; 2006 Nov; 54(11):3441-51. PubMed ID: 17075836
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
Bouterfa HL; Sattelmeyer V; Czub S; Vordermark D; Roosen K; Tonn JC
Anticancer Res; 2000; 20(4):2761-71. PubMed ID: 10953355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
